Frequently asked questions

Clinrol helps connect patients with clinical research opportunities and supports the teams running clinical trials. Its tools help research sites manage patient enquiries, pre-screening and follow-up, while helping sponsors and contract research organisations (CROs) coordinate patient recruitment.

Clinrol Connect supports research-site recruitment operations, including patient enquiries, pre-screening, calls, SMS, appointments and follow-up. Clinrol Recruit supports patient recruitment campaigns for sponsors and CROs, from outreach through to referral to participating research sites.

No. Clinrol helps people explore clinical trial opportunities and communicate with research teams. It does not diagnose conditions, recommend treatments or replace advice from your healthcare professional.

Start by exploring trials related to your condition and location. Read the study information and contact the research team about opportunities that interest you. A potentially relevant result is a starting point—not confirmation that you are eligible or that a place is available.

No. Each trial has specific eligibility criteria, which may include your age, diagnosis, treatment history and other health information. The research team must assess your suitability and confirm whether the study is accepting participants at your chosen location.

Depending on the study, you may be contacted to discuss your interest and answer initial screening questions. If further assessment is appropriate, the research team will explain the next steps. Sending an enquiry does not commit you to participating.

Pre-screening is an initial check of information such as your condition, location and relevant health history against a study’s requirements. It helps identify whether further assessment may be worthwhile. It does not replace the research team’s screening or informed-consent process.

No. Clinical trials can involve risks, side effects and uncertainty, and participation may not benefit you personally. Before you decide, the research team should explain the study’s purpose, procedures, potential risks and benefits, and alternatives. You can discuss these with your usual healthcare professional.

Yes. Clinical trial participation is voluntary. You can decline to join or withdraw after joining. Tell the research team if you want to withdraw so they can explain any recommended safety checks or follow-up, and how information already collected will be handled.

This varies by study. Some trials offer reimbursement for expenses or compensation for time and inconvenience; others do not. Ask the research team what study-related care is covered and whether travel, accommodation or other expenses are your responsibility.

Clinrol Connect brings recruitment activities together, including patient enquiries, pre-screening, calls, SMS, appointment scheduling and follow-up. It is designed to help coordinators organise their workload and track patients through the recruitment process.

Ayla is Clinrol’s AI calling assistant. It can support initial patient conversations using configured screening questions and help collect information for the research team to review. It supports staff workflows rather than replacing clinical judgement.

No. AI-assisted pre-screening can help collect information and identify potential matches. The authorised research team remains responsible for assessing eligibility, explaining the study and completing the required consent process.

Clinrol Connect focuses on patient recruitment and engagement. It can complement your existing clinical trial management system rather than replace it. Discuss your current systems and requirements with the Clinrol team to establish the right setup.

Integration requirements depend on your systems and intended workflow. Share the tools you use with the Clinrol team so they can confirm available connections, any custom work required and how information would move between systems.

Clinrol Recruit supports patient outreach, initial pre-screening and referral to participating research sites. It also helps teams monitor recruitment activity across campaigns and sites. The appropriate approach depends on the study population, eligibility criteria and locations.

Enrolment depends on factors including study eligibility, patient interest, site capacity and screening outcomes. Recruitment enquiries and referrals should not be treated as confirmed enrolments. Agree on objectives, reporting definitions and expectations before starting a campaign.

Pricing depends on the product, study requirements, participating sites and scope of services. Contact Clinrol to discuss your needs and request a tailored proposal.

Yes. You can help patients understand available study information and identify opportunities to discuss with the relevant research team. A referral or enquiry does not confirm eligibility or mean that a trial is the most appropriate option for that patient.

A referral is an introduction to a research opportunity, not a transfer of care. If the patient enrols, the research team should explain how study visits and treatments will be coordinated with their usual healthcare providers.

Discuss why the trial may be relevant, the uncertainty involved and any practical considerations such as location or visit frequency. Obtain the patient’s permission before sharing personal or health information, and use the approved referral process.